SalubrisBio parent company Salubris Pharmaceuticals announces investment of $8M in Mercator Medsystems (Emeryville, USA) to support development of their novel microinjection platform technology
By: jonadmin|Published on: Oct 27, 2020|Categories: |
By: jonadmin|Published on: Oct 27, 2020|Categories: |
Recent Comments